DCE-MRI of the Breast in a Stand-alone Setting Outside a Complementary Strategy - Results of the TK-study

Overview

Journal Eur Radiol

Specialty Radiology

Date 2015 Jan 12

PMID 25577524

Citations 7

Authors

Clemens G Kaiser

C Reich

M Dietzel

P A T Baltzer

J Krammer

K Wasser

S O Schoenberg

W A Kaiser

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the accuracy of MRI of the breast (DCE-MRI) in a stand-alone setting with extended indications.

Materials And Methods: According to the inclusion criteria, breast specialists were invited to refer patients to our institution for DCE-MRI. Depending on the MR findings, patients received either a follow-up or biopsy. Between 04/2006 and 12/2011 a consecutive total of 1,488 women were prospectively examined.

Results: Of 1,488 included patients, 393 patients were lost to follow-up, 1,095 patients were evaluated. 124 patients were diagnosed with malignancy by DCE-MRI (76 TP, 48 FP, 971 TN, 0 FN cases). Positive cases were confirmed by histology, negative cases by MR follow-ups or patient questionnaires over the next 5 years in 1,737 cases (sensitivity 100 %; specificity 95.2 %; PPV 61.3 %; NPV 100 %; accuracy 95.5 %). For invasive cancers only (DCIS excluded), the results were 63 TP; 27 FP; 971 TP and 0 FN (sensitivity 100 %; specificity 97.2 %; PPV 70 %; NPV 100 %; accuracy 97.5 %).

Conclusion: The DCE-MRI indications tested imply that negative results in DCE-MRI reliably exclude cancer. The results were achieved in a stand-alone setting (single modality diagnosis). However, these results are strongly dependent on reader experience and adequate technical standards as prerequisites for optimal diagnoses.

Key Points: • DCE-MRI of the breast has a high accuracy in finding breast cancer. • The set of indications for DCE-MRI of the breast is still very limited. • DCE-MRI can achieve a high accuracy in a 'screening-like' setting. • Accuracy of breast DCE-MRI is strongly dependent on technique and reader experience. • A negative DCE-MRI effectively excludes cancer.

Citing Articles

Optimizing ultrafast dynamic contrast-enhanced MRI scan duration in the differentiation of benign and malignant breast lesions.

Cao Y, Huang Y, Chen X, Wang W, Chen H, Yin T Insights Imaging. 2024; 15(1):112.

PMID: 38713334 PMC: 11076431. DOI: 10.1186/s13244-024-01697-6.

Economic evaluation of breast MRI in screening - a systematic review and basic approach to cost-effectiveness analyses.

Tollens F, Baltzer P, Froelich M, Kaiser C Front Oncol. 2023; 13:1292268.

PMID: 38130995 PMC: 10733447. DOI: 10.3389/fonc.2023.1292268.

Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?.

Tollens F, Baltzer P, Dietzel M, Rubenthaler J, Froelich M, Kaiser C Cancers (Basel). 2021; 13(6).

PMID: 33808955 PMC: 8000655. DOI: 10.3390/cancers13061241.

Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.

Froelich M, Kaiser C Eur Radiol. 2020; 31(2):967-974.

PMID: 32856166 PMC: 7813739. DOI: 10.1007/s00330-020-07129-5.

DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.

Sun X, Yang L, Yan X, Sun Y, Zhao D, Ji Y PLoS One. 2016; 11(9):e0162601.

PMID: 27632532 PMC: 5025193. DOI: 10.1371/journal.pone.0162601.

References

Benndorf M, Baltzer P, Vag T, Gajda M, Runnebaum I, Kaiser W . Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes. Acta Radiol. 2010; 51(7):715-21. DOI: 10.3109/02841851.2010.497164. View

Lehman C, Gatsonis C, Kuhl C, Hendrick R, Pisano E, Hanna L . MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007; 356(13):1295-303. DOI: 10.1056/NEJMoa065447. View

Fischer U . [X-ray mammography : calcifications, masses and architectural distortions]. Radiologe. 2008; 48(8):785-97, quiz 798. DOI: 10.1007/s00117-008-1711-0. View

Edwards S, Lipson J, Ikeda D, Lee J . Updates and revisions to the BI-RADS magnetic resonance imaging lexicon. Magn Reson Imaging Clin N Am. 2013; 21(3):483-93. DOI: 10.1016/j.mric.2013.02.005. View

Ko E, Lee B, Choi H, Kim R, Noh W . Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound. Eur J Radiol. 2010; 80(3):719-23. DOI: 10.1016/j.ejrad.2010.07.019. View

Bocker W . [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics]. Verh Dtsch Ges Pathol. 2003; 86:116-9. View

Pinker K, Bogner W, Baltzer P, Trattnig S, Gruber S, Abeyakoon O . Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T. Eur Radiol. 2013; 24(4):913-20. DOI: 10.1007/s00330-013-3075-8. View

Folkman J . Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971; 285(21):1182-6. DOI: 10.1056/NEJM197111182852108. View

Mann R, Mus R, van Zelst J, Geppert C, Karssemeijer N, Platel B . A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging. Invest Radiol. 2014; 49(9):579-85. DOI: 10.1097/RLI.0000000000000057. View

10.

Mann R, Kuhl C, Kinkel K, Boetes C . Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008; 18(7):1307-18. PMC: 2441490. DOI: 10.1007/s00330-008-0863-7. View

11.

Houssami N, Hayes D . Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?. CA Cancer J Clin. 2009; 59(5):290-302. DOI: 10.3322/caac.20028. View

12.

Tabar L, Tony Chen H, Amy Yen M, Tot T, Tung T, Chen L . Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer. 2004; 101(8):1745-59. DOI: 10.1002/cncr.20582. View

13.

Baltzer P, Dietzel M, Kaiser W . A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol. 2013; 23(8):2051-60. DOI: 10.1007/s00330-013-2804-3. View

14.

Kuhl C, Schrading S, Strobel K, Schild H, Hilgers R, Bieling H . Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol. 2014; 32(22):2304-10. DOI: 10.1200/JCO.2013.52.5386. View

15.

Echevarria J, Martin M, Saiz A, Imaz I, Fernandez-Ruanova B, Martin D . Overall breast density in MR mammography: diagnostic and therapeutic implications in breast cancer. J Comput Assist Tomogr. 2005; 30(1):140-7. DOI: 10.1097/01.rct.0000191684.51215.9c. View

16.

Morris E . Rethinking breast cancer screening: ultra FAST breast magnetic resonance imaging. J Clin Oncol. 2014; 32(22):2281-3. DOI: 10.1200/JCO.2014.56.1514. View

17.

Kuhl C . The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007; 244(2):356-78. DOI: 10.1148/radiol.2442051620. View

18.

Merckel L, Verkooijen H, Peters N, Mann R, Veldhuis W, Storm R . The added diagnostic value of dynamic contrast-enhanced MRI at 3.0 T in nonpalpable breast lesions. PLoS One. 2014; 9(4):e94233. PMC: 3979776. DOI: 10.1371/journal.pone.0094233. View

19.

Clauser P, Pinker K, Helbich T, Kapetas P, Bernathova M, Baltzer P . Fat saturation in dynamic breast MRI at 3 Tesla: is the Dixon technique superior to spectral fat saturation? A visual grading characteristics study. Eur Radiol. 2014; 24(9):2213-9. DOI: 10.1007/s00330-014-3189-7. View

20.

Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert F . Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010; 46(8):1296-316. DOI: 10.1016/j.ejca.2010.02.015. View